Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice

Recombinant vesicular stomatitis virus (rVSV) has shown great potential as a new viral vector for vaccination. However, the prototypic rVSV vector described previously was found to be insufficiently attenuated for clinical evaluation when assessed for neurovirulence in nonhuman primates. Here, we de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cooper, David, Wright, Kevin J., Calderon, Priscilla C., Guo, Min, Nasar, Farooq, Johnson, J. Erik, Coleman, John W., Lee, Margaret, Kotash, Cheryl, Yurgelonis, Irene, Natuk, Robert J., Hendry, R. Michael, Udem, Stephen A., Clarke, David K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology (ASM) 2008
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224363/
https://ncbi.nlm.nih.gov/pubmed/17942549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01515-07
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge